Skip to search formSkip to main contentSkip to account menu

insulin degludec

Known as: (1A-21A),(1B-29B)-insulin (human), 29B-(N6-(N-(15-carboxy-1- oxopentadecyl)-L-gamma- glutamyl)-L-lysine)-, INSULIN,DEGLUDEC,HUMAN/RDNA, degludec 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objective With healthcare systems under increasing financial pressure from costs associated with diabetes care, it is important… 
2016
2016
BackgroundThe effects of insulin on cardiomyocytes, such as positive inotropic action and glucose uptake are well described… 
2014
2014
Insulin degludec (IDeg) is a new basal insulin with an ultra‐long and stable glucose‐lowering effect. We compared once‐daily IDeg… 
2013
2013
Background: Changes in the day-to-day variability in the glucose-lowering effect of insulin [fluctuations of blood glucose levels… 
Review
2012
Review
2012
The basal-bolus concept of delivering insulin to diabetic patients makes physiological sense, as it mimics normal insulin release… 
2005
2005
The follow up of patients with chronic liver diseases and the data from multicentric clinical studies are affected by the… 
2002
2002
Chemotherapy-induced cell death is linked to apoptosis, and there is increasing evidence that multidrug-resistance in cancer… 
1997
1997
The BB rat model of human insulin-dependent diabetes mellitus (IDDM) spontaneously develops diabetes through an autoimmune… 
1995
1995
A novel rat basophilic leukemia (RBL) 2H3 subline of rat mucosal mast cells deficient in the expression of the gamma chain (RBL… 
1988
1988
DNA amplification combined with hybridization with 32P-labeled synthetic oligonucleotide probes has been used to identify base…